Relation between body mass index, physical inactivity and use of prescription drugs: The Doetinchem Cohort Study

International Journal of Obesity

Volumn 34, Issue 6, 2010, Pages 1060-1069

  Milder, I E J ^a   Klungel, O H ^b   Mantel Teeuwisse, A K ^b   Verschuren, W M M ^a   Bemelmans, W J E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Body mass index; Medication; Physical inactivity

Indexed keywords

ADULT; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMATOPOIETIC SYSTEM; HUMAN; IMMOBILIZATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; WORLD HEALTH ORGANIZATION;

BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; OBESITY; PRESCRIPTION DRUGS; QUESTIONNAIRES; RISK FACTORS; SEDENTARY LIFESTYLE; SEX FACTORS; SMOKING;

EID: 77953609272     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.2     Document Type: Article

References (26)

1. Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Public Health 2001; 22: 355-375.
2. Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007; 167: 1720-1728.
3. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1423-1434.
4. Weinstein AR, Sesso HD. Joint effects of physical activity and body weight on diabetes and cardiovascular disease. Exerc Sport Sci Rev 2006; 34: 10-15.
5. US Department of Health and Human Services. Physical Activity and Health. Centers for Disease Control and Prevention: Atlanta, GA, 1996.
6. Helmrich SP, Ragland DR, Leung RW, Paffenbarger Jr RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325: 147-152.
7. Muller-Riemenschneider F, Reinhold T, Berghofer A, Willich SN. Health-economic burden of obesity in Europe. Eur J Epidemiol 2008; 23: 499-509.
8. Van Mosseveld C. SHA-Based Health Accounts in 13 OECD Countries: Country Studies: The Netherlands. OECD: Paris, France, 2001.
9. van Dijk L, Otters HB, Schuit AJ. Moderately overweight and obese patients in general practice: a population based survey. BMC Fam Pract 2006; 7: 43.
10. The Counterweight Project Team. The impact of obesity on drug prescribing in primary care. Br J Gen Pract 2005; 55: 743-749.
11. Esposti ED, Sturani A, Valpiani G, Di Martino M, Ziccardi F, Rita Cassani A et al. The relationship between body weight and drug costs: An Italian population-based study. Clin Ther 2006; 28: 1472-1481.
12. Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med 2004; 164: 2135-2140.
13. Narbro K, Agren G, Jonsson E, Naslund I, Sjostrom L, Peltonen M. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002; 162: 2061-2069.
14. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res 2001; 9: 210-218.
15. Trakas K, Lawrence K, Shear NH. Utilization of health care resources by obese Canadians. CMAJ 1999; 160: 1457-1462.
16. Eggen AE. Pattern of drug use in a general populationF prevalence and predicting factors: the Tromso study. Int J Epidemiol 1994; 23: 1262-1272.
17. Bardel A, Wallander MA, Svardsudd K. Reported current use of prescription drugs and some of its determinants among 35 to 65-year-old women in mid-Sweden: a population-based study. J Clin Epidemiol 2000; 53: 637-643.
18. Brekke M, Hunskaar S, Straand J. Self-reported drug utilization, health, and lifestyle factors among 70-74 year old community dwelling individuals in Western Norway. The Hordaland Health Study (HUSK). BMC Public Health 2006; 6: 121.
19. Bertoldi AD, Hallal PC, Barros AJ. Physical activity and medicine use: evidence from a population-based study. BMC Public Health 2006; 6: 224.
20. Verschuren WMM, Blokstra A, Picavet HSJ, Smit HA. Cohort profile: the Doetinchem Cohort Study. Int J Epidemiol 2009; 37: 1236-1241.
21. Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther 2008; 33: 17-23.
22. Pols MA, Peeters PH, Ocke MC, Bueno-de-Mesquita HB, Slimani N, Kemper HC et al. Relative validity and repeatability of a new questionnaire on physical activity. Prev Med 1997; 26: 37-43.
23. Ainsworth BE, Haskell WL, Leon AS, Jacobs Jr DR, Montoye HJ, Sallis JF et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71-80.
24. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger Jr WH, Kostis JB et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279: 839-846.
25. Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320: 827-832.
26. Trento M, Passera P, Bajardi M, Tomalino M, Grassi G, Borgo E et al. Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia 2002; 45: 1231-1239.